Ocular Therapeutix OCUL
NASDAQ OCUL
$6.48 -0.17 (-2.56%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Long-Term Debt Issuances (2017 - 2019)

Updated

Ocular Therapeutix's Long-Term Debt Issuances was $82.47 million in FY2023.

Analysis

Ocular Therapeutix (OCUL) Long-Term Debt Issuances (2017 - 2019) Analysis & Trends

From FY2012 onward, Ocular Therapeutix has reported Long-Term Debt Issuances for 9 years.

  • Long-Term Debt Issuances shows a five-year compound annual growth rate of 47.0% (FY2018 to FY2023).
  • The FY2023 figure marks the highest annual Long-Term Debt Issuances in data going back to FY2012.
  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $3.72 million in FY2021 (+16.3%), $3.2 million in FY2020 (-91.4%) and $37.28 million in FY2019 (+209.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Ocular Therapeutix 1.45 Bn -895.10 Mn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -70,000.00
Mar 31, 2019 37.35 Mn
Mar 31, 2017 3.70 Mn
API Access

Ocular Therapeutix Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=OCUL&period=max&api_key=YOUR_API_KEY